PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15207225

[Insulin pumps].

Pilar Martín Vaquero·Alberto Fernández Martínez·Luis Felipe Pallardo
View original source ↗Export metadata ↓

Abstract

Treatment with insulin in form of continued subcutaneous infusions is intended to mimic the normal pancreatic function. Insulin pumps are currently a reality and they allow for an improvement of glycemic oscillations and contribute to decrease HbA1c and to improve patient's quality of life. Infusion systems are quite advanced and the challenge at present are glycemia sensors. There are several trials under way which are trying to establish if it is possible for sensors to work with a closed-loop system. In the meantime, patients will continue to perform (and interpret) glycemic controls. The role of physicians must be to advice patients about diabetes and the management of pumps so that they are able to minimize hypoglycemias and optimize glycemic controls.

Explore related subjects

Insulin Infusion SystemsEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pilar Martín Vaquero, Alberto Fernández Martínez, Luis Felipe Pallardo. 2004-06-05. [Insulin pumps].. https://doi.org/10.1016/s0025-7753(04)74400-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1983

The electro-osmotic actuation of implantable insulin micropumps.

A study using an electro-osmotic cell suitable for actuating an implantable insulin micropump showed that controlled variable flow rates in the order of 0.2 mL/day are possible. The cell functioned continuously with low energy and power requirements and long service life. The principle of operation is compatible with achieving the very low flow rates necessary if highly concentrated insulin is to be used to avoid frequent insulin reservoir refilling. An electro-osmotic cell, Ag/AgCl/NaCl(aq)/cation exchange membrane/NaCl(aq)/AgCl/Ag, was connected to a constant current power supply which reversed the direction of the current every 10 mins causing a to-and-fro transport of fluid through the membrane. Flow rates of 0.15-0.60 microL/min were achieved with currents of 2.5-10 mA. At the low flow rate, energy consumption was 6.4 X 10(-2) J/microL and peak power requirement was less than 2.0 X 10(-4) W. Fluid was transported against a pressure gradient of 52 cm Hg. The cell contained a total electrolyte volume of less than 0.25 mL. The membrane showed no change in properties after 10,000 current reversals (69 days). To function as an actuator for an implantable insulin micropump, the electro-osmotic cell requires a switching and valving assembly; a suitable design for this is briefly considered.

Insulin Infusion Systems↗
PubMed1983

Insulin pumps. A technical review.

The technique employed in open-loop insulin infusion pumps is reviewed. Most commonly used syringe as well as peristaltic pumps are exemplified. Their weights and prices are compared. Possibilities of development are discussed.

Insulin Infusion Systems↗